Notice2023-11158

Bulk Manufacturer of Controlled Substances Application: Benuvia Operations LLC

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 25, 2023

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Benuvia Operations LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 101 (Thursday, May 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 101 (Thursday, May 25, 2023)]
[Notices]
[Pages 33910-33911]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11158]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1181]


Bulk Manufacturer of Controlled Substances Application: Benuvia 
Operations LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Benuvia Operations LLC. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
July 24, 2023. Such persons may also file a written request for a 
hearing on the application on or before July 24, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 9, 2023, Benuvia Operations, LLC., 3950 North 
Mays Street, Round Rock, Texas 78665, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Ibogaine.............................        7260  I
Lysergic Acid Diethylamide...........        7315  I
Tetrahydrocannabinols................        7370  I
Mescaline............................        7381  I

[[Page 33911]]

 
3, 4-Methylenedioxyamphetamine.......        7400  I
3, 4-Methylenedioxymethamphetamine...        7405  I
5-Methoxy-N-N-dimethyltryptamine.....        7431  I
Dimethyltryptamine...................        7435  I
Psilocybin...........................        7437  I
Psilocyn.............................        7438  I
5-Methoxy-N, N-diisopropyltryptamine.        7439  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. In reference to dug codes 7370 (Tetrahydrocannabinols), the 
company plans to bulk manufacture this drug as synthetic. No other 
activities for these drug codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-11158 Filed 5-24-23; 8:45 am]
BILLING CODE P


</pre></body>
</html>
Indexed from Federal Register on May 25, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.